This announcement is a separate document:
康弘药业：关于2021年股票期权激励计划首次授予部分第三个行权期自主行权的提示性公告
Kanghong Pharmaceutical: An indicative announcement on the 2021 Stock Options Incentive Plan granting autonomous exercise rights for part of the third exercise period for the first time
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.